Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beta Bionics (BBNX) Treasury Shares (2025)

Beta Bionics (BBNX) has disclosed Treasury Shares for 1 consecutive years, with $753885.0 as the latest value for Q4 2025.

  • Quarterly Treasury Shares changed N/A to $753885.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $753885.0 through Dec 2025, changed N/A year-over-year, with the annual reading at $753885.0 for FY2025, N/A changed from the prior year.
  • Treasury Shares hit $753885.0 in Q4 2025 for Beta Bionics, down from $824771.0 in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $937063.0 in Q1 2025 to a low of $753885.0 in Q4 2025.